AI-generated summary
Nine patients with facial telangiectasias had one cheek treated with a single high-fluence purpuric pulsed dye laser pass and the other cheek with four low-fluence subpurpuric passes. The authors report that the purpuric pass reduced vessel surface area and diameter more, while the subpurpuric approach reduced background erythema more, and that the subpurpuric approach was cosmetically acceptable. The study was small and involved only nine patients.
- Participants
- 9
- Who or what was studied
- Nine patients with facial telangiectasias
- Limits stated in the abstract
- The study included only nine patients and assessed outcomes at a single three-week time point.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.